BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31385006)

  • 1. Peri-tumoral Metallic Implants Reduce the Efficacy of Irreversible Electroporation for the Ablation of Colorectal Liver Metastases.
    Cornelis FH; Cindrič H; Kos B; Fujimori M; Petre EN; Miklavčič D; Solomon SB; Srimathveeravalli G
    Cardiovasc Intervent Radiol; 2020 Jan; 43(1):84-93. PubMed ID: 31385006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irreversible Electroporation to Treat Unresectable Colorectal Liver Metastases (COLDFIRE-2): A Phase II, Two-Center, Single-Arm Clinical Trial.
    Meijerink MR; Ruarus AH; Vroomen LGPH; Puijk RS; Geboers B; Nieuwenhuizen S; van den Bemd BAT; Nielsen K; de Vries JJJ; van Lienden KP; Lissenberg-Witte BI; van den Tol MP; Scheffer HJ
    Radiology; 2021 May; 299(2):470-480. PubMed ID: 33724066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-center nonrandomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: Short to mid-term results.
    Frühling P; Nilsson A; Duraj F; Haglund U; Norén A
    Eur J Surg Oncol; 2017 Apr; 43(4):751-757. PubMed ID: 28109674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irreversible Electroporation for Colorectal Liver Metastases.
    Scheffer HJ; Melenhorst MC; Echenique AM; Nielsen K; van Tilborg AA; van den Bos W; Vroomen LG; van den Tol PM; Meijerink MR
    Tech Vasc Interv Radiol; 2015 Sep; 18(3):159-69. PubMed ID: 26365546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ablation of colorectal liver metastases by irreversible electroporation: results of the COLDFIRE-I ablate-and-resect study.
    Scheffer HJ; Nielsen K; van Tilborg AA; Vieveen JM; Bouwman RA; Kazemier G; Niessen HW; Meijer S; van Kuijk C; van den Tol MP; Meijerink MR
    Eur Radiol; 2014 Oct; 24(10):2467-75. PubMed ID: 24939670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal liver metastatic disease: efficacy of irreversible electroporation--a single-arm phase II clinical trial (COLDFIRE-2 trial).
    Scheffer HJ; Vroomen LG; Nielsen K; van Tilborg AA; Comans EF; van Kuijk C; van der Meijs BB; van den Bergh J; van den Tol PM; Meijerink MR
    BMC Cancer; 2015 Oct; 15():772. PubMed ID: 26497813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent Colorectal Liver Metastases in the Liver Remnant After Major Liver Surgery-IRE as a Salvage Local Treatment When Resection and Thermal Ablation are Unsuitable.
    Hitpass L; Distelmaier M; Neumann UP; Schöning W; Isfort P; Keil S; Kuhl CK; Bruners P; Barabasch A
    Cardiovasc Intervent Radiol; 2022 Feb; 45(2):182-189. PubMed ID: 34757483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microwave Ablation, Radiofrequency Ablation, Irreversible Electroporation, and Stereotactic Ablative Body Radiotherapy for Intermediate Size (3-5 cm) Unresectable Colorectal Liver Metastases: a Systematic Review and Meta-analysis.
    Nieuwenhuizen S; Dijkstra M; Puijk RS; Geboers B; Ruarus AH; Schouten EA; Nielsen K; de Vries JJJ; Bruynzeel AME; Scheffer HJ; van den Tol MP; Haasbeek CJA; Meijerink MR
    Curr Oncol Rep; 2022 Jun; 24(6):793-808. PubMed ID: 35298796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous irreversible electroporation for the treatment of colorectal cancer liver metastases with a proposal for a new response evaluation system.
    Hosein PJ; Echenique A; Loaiza-Bonilla A; Froud T; Barbery K; Rocha Lima CM; Yrizarry JM; Narayanan G
    J Vasc Interv Radiol; 2014 Aug; 25(8):1233-1239.e2. PubMed ID: 24861662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irreversible electroporation of hepatocellular carcinoma and colorectal cancer liver metastases: A nationwide multicenter study with short- and long-term follow-up.
    Frühling P; Stillström D; Holmquist F; Nilsson A; Freedman J
    Eur J Surg Oncol; 2023 Nov; 49(11):107046. PubMed ID: 37716017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent validation of CT radiomics models in colorectal liver metastases: predicting local tumour progression after ablation.
    van der Reijd DJ; Guerendel C; Staal FCR; Busard MP; De Oliveira Taveira M; Klompenhouwer EG; Kuhlmann KFD; Moelker A; Verhoef C; Starmans MPA; Lambregts DMJ; Beets-Tan RGH; Benson S; Maas M
    Eur Radiol; 2024 Jun; 34(6):3635-3643. PubMed ID: 37987835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal liver metastases: making the unresectable resectable using irreversible electroporation for microscopic positive margins - a case report.
    Schoellhammer HF; Goldner B; Merchant SJ; Kessler J; Fong Y; Gagandeep S
    BMC Cancer; 2015 Apr; 15():271. PubMed ID: 25886376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ablation of Locally Advanced Pancreatic Cancer with Percutaneous Irreversible Electroporation: Results of the Phase I/II PANFIRE Study.
    Scheffer HJ; Vroomen LG; de Jong MC; Melenhorst MC; Zonderhuis BM; Daams F; Vogel JA; Besselink MG; van Kuijk C; Witvliet J; de van der Schueren MA; de Gruijl TD; Stam AG; van den Tol PM; van Delft F; Kazemier G; Meijerink MR
    Radiology; 2017 Feb; 282(2):585-597. PubMed ID: 27604035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effectiveness of irreversible electroporation in a murine model of colorectal liver metastasis.
    Sánchez-Velázquez P; Castellví Q; Villanueva A; Iglesias M; Quesada R; Pañella C; Cáceres M; Dorcaratto D; Andaluz A; Moll X; Burdío JM; Grande L; Ivorra A; Burdío F
    Sci Rep; 2017 Mar; 7():44821. PubMed ID: 28327623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irreversible Electroporation for Unresectable Hepatocellular Carcinoma: Initial Experience.
    Kalra N; Gupta P; Gorsi U; Bhujade H; Chaluvashetty SB; Duseja A; Singh V; Dhiman RK; Chawla YK; Khandelwal N
    Cardiovasc Intervent Radiol; 2019 Apr; 42(4):584-590. PubMed ID: 30697637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous ablation of peribiliary tumors with irreversible electroporation.
    Silk MT; Wimmer T; Lee KS; Srimathveeravalli G; Brown KT; Kingham PT; Fong Y; Durack JC; Sofocleous CT; Solomon SB
    J Vasc Interv Radiol; 2014 Jan; 25(1):112-8. PubMed ID: 24262034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasound-guided percutaneous irreversible electroporation of hepatic and abdominal tumors not eligible for surgery or thermal ablation: a western report on safety and efficacy.
    Giorgio A; Amendola F; Calvanese A; Ingenito E; Santoro B; Gatti P; Ciracì E; Matteucci P; Giorgio V
    J Ultrasound; 2019 Mar; 22(1):53-58. PubMed ID: 30843171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immediate Postablation
    Cornelis FH; Petre EN; Vakiani E; Klimstra D; Durack JC; Gonen M; Osborne J; Solomon SB; Sofocleous CT
    J Nucl Med; 2018 Sep; 59(9):1360-1365. PubMed ID: 29439012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ablation of a liver metastasis with irreversible electroporation (IRE) in liver segment II adjoining the area nuda].
    Niessen C; Jung EM; Stroszczynski C; Wiggermann P
    Rofo; 2012 Oct; 184(10):937-8. PubMed ID: 22744330
    [No Abstract]   [Full Text] [Related]  

  • 20. Percutaneous Ablation of Hepatic Tumors Using Irreversible Electroporation: A Prospective Safety and Midterm Efficacy Study in 34 Patients.
    Niessen C; Beyer LP; Pregler B; Dollinger M; Trabold B; Schlitt HJ; Jung EM; Stroszczynski C; Wiggermann P
    J Vasc Interv Radiol; 2016 Apr; 27(4):480-6. PubMed ID: 26922979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.